Gerardo C Glikin
Overview
Explore the profile of Gerardo C Glikin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allende J, Finocchiaro L, Glikin G
Vet Comp Oncol
. 2021 Nov;
20(2):372-380.
PMID: 34724324
We tested the efficacy of a yeast cytosine deaminase::uracil phosphoribosyl transferase/5-fluorocytosine (CDU/5-FC) non-viral suicide system on eight established canine melanoma cell lines. Albeit with different degree of sensitivity 5 days...
2.
Fondello C, Agnetti L, Glikin G, Finocchiaro L
Melanoma Res
. 2020 Mar;
30(2):126-135.
PMID: 32142496
In our veterinary clinical trials, the combination of systemic immunotherapy with local herpes simplex virus thymidine kinase/ganciclovir suicide gene (SG) treatment induced tumor pseudoprogression as part of a strong local...
3.
Agnetti L, Fondello C, Arbe M, Glikin G, Finocchiaro L
Gene Ther
. 2020 Mar;
28(1-2):38-55.
PMID: 32127652
In the context of comparative oncology, melanoma cells derived from companion animal tumors are good models for optimizing and predicting their in vivo response to therapeutic strategies. Here, we report...
4.
Finocchiaro L, Agnetti L, Fondello C, Glikin G
Gene Ther
. 2019 Mar;
26(10-11):418-431.
PMID: 30858538
After 6 years of follow-up treating 364 canine melanoma patients, we present here results about the proof-of-concept, safety, and efficacy of a new surgery adjuvant combined gene therapy. The adjuvant...
5.
Finocchiaro L, Spector A, Agnetti L, Arbe M, Glikin G
Vet Sci
. 2018 Aug;
5(3).
PMID: 30081470
The incidence of canine mammary carcinoma varies with age, breed, and spay status, being among the main tumors appearing in intact female dogs. Thirty-six canine mammary carcinoma patients received injections...
6.
Fondello C, Agnetti L, Glikin G, Finocchiaro L
Anticancer Agents Med Chem
. 2018 Jun;
18(9):1338-1348.
PMID: 29866016
Background: Three metastatic human melanoma cell lines generated from patient removed lymph nodes and spleen metastasis were established in our laboratory. Objective: To investigate the mechanisms enhancing the cytotoxic effects...
7.
Agnetti L, Fondello C, Villaverde M, Glikin G, Finocchiaro L
Oncoscience
. 2018 Jan;
4(11-12):199-214.
PMID: 29344558
We originated and characterized melanoma cell lines derived from tumors of two feline and two canine veterinary patients. These lines reestablished the morphology, physiology and cell heterogeneity of their respective...
8.
Finocchiaro L, Glikin G
World J Exp Med
. 2017 Jun;
7(2):42-48.
PMID: 28589078
This mini-review presents the results of veterinary clinical trials on immunogene therapy published from 2014 to 2016. A variety of tumors, among them melanoma (canine and equine), mastocytoma (canine), mammary...
9.
Rossi U, Finocchiaro L, Glikin G
Anticancer Agents Med Chem
. 2016 Sep;
17(5):754-761.
PMID: 27677689
Background: Malignant melanoma is a fast growing form of skin cancer with increasing global incidence. Clinically, canine malignant melanoma and human melanoma share comparable treatment-resistances, metastatic phenotypes and site selectivity....
10.
Fondello C, Agnetti L, Villaverde M, Simian M, Glikin G, Finocchiaro L
Biomed Pharmacother
. 2016 Jul;
83:290-301.
PMID: 27399807
We explored the potential of a chemogene therapy combination to eradicate melanoma tumor initiating cells, key producers of recurrence and metastatic spread. Three new human melanoma cell lines, two obtained...